Cutting-edge Biotechnology 3DBio Therapeutics is a clinical-stage biotechnology company specializing in regenerative medicine through innovative 3D-bioprinting technologies, presenting a unique opportunity for partnerships with healthcare providers seeking cutting-edge solutions.

Highly Skilled Personnel The recent appointment of industry veterans Sol Barer, Ph.D., and Kevin Slawin, M.D., to the 3DBio Therapeutics' Board of Directors signals a strengthening of leadership, offering a potential channel for networking with key decision-makers in the biotechnology sector.

Innovative Tech Stack 3DBio leverages a diverse tech stack including RSS, MySQL, and 3D-bioprinting tools, showcasing a commitment to advanced technologies that could be of interest to tech companies looking to collaborate on groundbreaking projects.

Strategic Location in NY Located in Long Island City, NY, 3DBio is situated in a hub of biotech innovation, making it an attractive target for local partnerships and collaborations with research institutions, universities, and bio-pharmaceutical companies.

Investment and Growth Potential Amidst a competitive landscape with companies like Celsius Therapeutics and Affinia Therapeutics, 3DBio's focus on personalized living tissues and organs presents a unique value proposition that could appeal to investors seeking opportunities in the biotechnology research sector.